Category: PUBLIC HEALTH INFORMATION

CDC Director Defends Changing School Distancing Recommendation

The director of the Centers for Disease Control and Prevention (CDC) on Sunday defended telling educators last year that social distancing in schools of three feet was “quite safe,” while her agency in new reopening guidance says six feet of distancing is recommended. “Over the summer, we were at much less disease, and our guidance…


CDC Director Explains Changing School Distancing Recommendation

The director of the Centers for Disease Control and Prevention (CDC) on Sunday defended telling educators last year that social distancing in schools of three feet was “quite safe,” while her agency in new reopening guidance says six feet of distancing is recommended. “Over the summer, we were at much less disease, and our guidance…


CDC’s Walensky Explains Changing School Distancing Recommendation

The director of the Centers for Disease Control and Prevention (CDC) defended telling educators last year that social distancing in schools of three feet was “quite safe,” while new reopening guidance from her agency says six feet of distancing is recommended. “Over the summer, we were at much less disease, and our guidance is a bit more…


COVID-19 Vaccine to be Tested in Children as Young as Six, University Says

Children as young as six will be part of a new COVID-19 vaccine trial, the University of Oxford announced Saturday. “Building on previous trials of the vaccine, which have shown that it is safe, produces strong immune system responses and has high efficacy in all adults, this trial will assess if children and young adults…


Not Perfect, but Saves Lives, AstraZeneca Says of COVID-19 Vaccine

AstraZeneca’s COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double supplies to more than 200 million doses per month by April. The two-dose shot, developed with Oxford University, has been hailed as a “vaccine for the world” because…


South Africa to Vaccinate Health Care Workers With J&J COVID-19 Vaccine as Part of an “Implementation Study”

South Africa will move forward with its phase one vaccination program to inoculate its health care workers with the Johnson & Johnson (J&J) COVID-19 vaccine, though the vaccine has not been granted an emergency authorization usage. Health Minister Zweli Mkhize said on Feb. 10 that the country could no longer wait to immunize its health…


South Africa to Vaccinate Health Care Workers With J&J COVID-19 Vaccine as Part of ‘Implementation Study’

South Africa will move forward with its phase one vaccination program to inoculate its health care workers with the Johnson & Johnson (J&J) COVID-19 vaccine, though the vaccine has not been granted an emergency authorization usage. Health Minister Zweli Mkhize said on Feb. 10 that the country could no longer wait to immunize its health…


Authorities Investigating After COVID-19 Vaccine Recipients Develop Rare Blood Disorder

Federal authorities are investigating after some COVID-19 vaccine recipients have developed the rare blood disorder thrombocytopenia, with at least several cases resulting in death. A Food and Drug Administration (FDA) spokesperson told The Epoch Times via email that the agency is investigating and assessing the reported cases. “At this time, we have not found a causal…


Authorities Probe Rare Blood Disorder Among Some COVID-19 Vaccine Recipients

Federal officials are investigating after some COVID-19 vaccine recipients have developed the rare blood disorder thrombocytopenia, with at least several cases resulting in death. The Food and Drug Administration (FDA) is investigating and assessing the reported cases, an agency spokesperson told The Epoch Times via email. “At this time, we have not found a causal relationship,” the…


Alzheimer’s, Dementia Patients More Likely to Die From COVID-19: Study

A new study, controlled for age, has found that dementia patients are at an increased risk of contracting COVID-19 and, when they do, are at higher risk of hospitalization and death than non-dementia COVID-19 patients. The study, published on Feb. 9 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, reviewed health records of…